JW Shinyak Corporation (067290) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.115x

Based on the latest financial reports, JW Shinyak Corporation (067290) has a cash flow conversion efficiency ratio of 0.115x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (₩4.46 Billion ≈ $3.03 Million USD) by net assets (₩38.73 Billion ≈ $26.25 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see JW Shinyak Corporation (067290) total market value for the company's overall valuation and market capitalisation.

JW Shinyak Corporation - Cash Flow Conversion Efficiency Trend (2007–2024)

This chart illustrates how JW Shinyak Corporation's cash flow conversion efficiency has evolved over time, based on yearly financial data.

JW Shinyak Corporation Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of JW Shinyak Corporation ranked by their cash flow conversion efficiency. Explore JW Shinyak Corporation (067290) cash flow quality to measure how well operating cash flow supports reported net income.

Company	Cash Flow Conversion Efficiency
Balyo SA PA:BALYO	-1.908x
Thai Plaspac Public Company Limited BK:TPAC	0.071x
Acconeer AB ST:ACCON	-0.079x
Mobile Infrastructure Corporation NASDAQ:BEEP	-0.010x
SciVision Biotech Inc TW:1786	0.026x
Leadtrend Technology Corp TW:3588	0.007x
Bombay Super Hybrid Seeds Limited NSE:BSHSL	0.508x
Definitive Healthcare Corp NASDAQ:DH	0.007x

Annual Cash Flow Conversion Efficiency for JW Shinyak Corporation (2007–2024)

The table below shows the annual cash flow conversion efficiency of JW Shinyak Corporation from 2007 to 2024. View latest JW Shinyak Corporation stock price today for real-time trading data and today's change.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2024-12-31	₩26.90 Billion ≈ $18.23 Million	₩8.44 Billion ≈ $5.72 Million	0.314x	+101.71%
2023-12-31	₩16.44 Billion ≈ $11.14 Million	₩2.56 Billion ≈ $1.73 Million	0.156x	+22.16%
2022-12-31	₩55.97 Billion ≈ $37.93 Million	₩7.13 Billion ≈ $4.83 Million	0.127x	-9.16%
2021-12-31	₩55.44 Billion ≈ $37.57 Million	₩7.77 Billion ≈ $5.27 Million	0.140x	+93.40%
2020-12-31	₩56.56 Billion ≈ $38.33 Million	₩4.10 Billion ≈ $2.78 Million	0.072x	+11.25%
2019-12-31	₩66.14 Billion ≈ $44.82 Million	₩4.31 Billion ≈ $2.92 Million	0.065x	-70.53%
2018-12-31	₩33.49 Billion ≈ $22.69 Million	₩7.40 Billion ≈ $5.02 Million	0.221x	+426.23%
2017-12-31	₩36.83 Billion ≈ $24.96 Million	₩-2.50 Billion ≈ $-1.69 Million	-0.068x	-451.98%
2016-12-31	₩38.60 Billion ≈ $26.16 Million	₩743.20 Million ≈ $503.66K	0.019x	+3608.61%
2015-12-31	₩40.23 Billion ≈ $27.26 Million	₩-22.08 Million ≈ $-14.96K	-0.001x	+98.99%
2014-12-31	₩42.46 Billion ≈ $28.77 Million	₩-2.31 Billion ≈ $-1.56 Million	-0.054x	-246.92%
2011-12-31	₩52.81 Billion ≈ $35.79 Million	₩1.95 Billion ≈ $1.32 Million	0.037x	-65.66%
2007-12-31	₩27.49 Billion ≈ $18.63 Million	₩2.96 Billion ≈ $2.01 Million	0.108x	--

About JW Shinyak Corporation

KQ:067290 Korea Pharmaceuticals

Market Cap

$100.24 Million

₩147.91 Billion KRW

Market Cap Rank

#19280 Global

#949 in Korea

Share Price

₩3560.00

Change (1 day)

+1.71%

52-Week Range

₩1254.00 - ₩3890.00

All Time High

₩10766.98